Paeoniflorin Improves Cardiac Function and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Rat Model of Acute Myocardial Infarction [Corrigendum]

This article refers to:

Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction

Chen H, Dong Y, He X, Li J, Wang J. Drug Des Devel Ther. 2018;12:823–836.

The authors have advised Figure 11D on page 833 is incorrect. Due to an error at the time of figure assembly Figure 10D and Figure 11D were duplicated. The correct Figure 11 is shown below.

Figure 11 Effect of the PF on the expression of Caspase-9 in rats with myocardial infarction (immunohistochemistry, ×200).

Note: (A) Sham-operated control, (B) model control, (C) captopril group, (D) low-dose group, (E) middle dose group and (F) high-dose group.
Abbreviation: PF, paeoniflorin.

The authors apologize for this error and advise it does not affect the results of the paper.